HSIC logo

Henry Schein, Inc. (HSIC) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

74.25$'dan işlem gören Henry Schein, Inc. (HSIC), $8.74B değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 49/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 8 Şub 2026
49/100 AI Puanı Hedef $78.14 (+5.2%) PD $8.74B Hacim 804.5K

Henry Schein, Inc. (HSIC) Sağlık ve Boru Hattı Genel Bakışı

CEOStanley Bergman
Çalışanlar25000
MerkezMelville, NY, US
Halka Arz Yılı1995
SektörHealthcare

Henry Schein (HSIC) is a leading global distributor of healthcare solutions, offering a comprehensive portfolio of products, technology, and value-added services to dental and medical professionals, leveraging its established distribution network and technology platforms to enhance practice efficiency and patient care.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 8 Şub 2026

Yatırım Tezi

Henry Schein presents a notable research candidate due to its established market position, diversified product portfolio, and focus on technology-driven solutions. With a current P/E ratio of 24.52 and a market capitalization of $9.67 billion, HSIC demonstrates financial stability and growth potential. The company's ongoing investments in practice management software and value-added services are expected to drive revenue growth and improve customer retention. Furthermore, the increasing demand for dental and medical products, coupled with the aging population and expanding healthcare access, provides a favorable backdrop for HSIC's continued success. The company's commitment to innovation and strategic acquisitions should further enhance its competitive advantage and drive long-term shareholder value. Investors may want to evaluate HSIC for its steady growth prospects and resilient business model.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market Cap of $9.67B reflects substantial investor confidence in Henry Schein's market position and future growth prospects.
  • P/E ratio of 24.52 indicates a reasonable valuation relative to its earnings, suggesting potential for further appreciation.
  • Gross Margin of 29.2% demonstrates the company's ability to maintain profitability while managing costs effectively.
  • The company's Beta of 0.89 suggests lower volatility compared to the overall market, making it a potentially stable investment.
  • Henry Schein's focus on Technology and Value-Added Services provides a competitive edge and drives customer loyalty.

Rakipler & Benzerleri

Güçlü Yönler

  • Global distribution network
  • Comprehensive product portfolio
  • Strong customer relationships
  • Focus on technology and innovation

Zayıflıklar

  • Dependence on third-party suppliers
  • Exposure to regulatory changes
  • Competition from other distributors
  • Profit margin of 3.0% is relatively low.

Katalizörler

  • Upcoming: Expansion of Technology and Value-Added Services to drive recurring revenue.
  • Ongoing: Strategic acquisitions to expand product portfolio and geographic reach.
  • Ongoing: Penetration of emerging markets to capitalize on growing healthcare demand.
  • Ongoing: Focus on digital dentistry to capture market share in the evolving dental industry.

Riskler

  • Potential: Economic downturns could reduce demand for healthcare products and services.
  • Potential: Increased competition could erode market share and profitability.
  • Potential: Supply chain disruptions could impact product availability and increase costs.
  • Potential: Changes in healthcare regulations could impact business operations and profitability.
  • Ongoing: Dependence on third-party suppliers exposes the company to potential disruptions.

Büyüme Fırsatları

  • Expansion of Technology and Value-Added Services: Henry Schein has a significant opportunity to expand its Technology and Value-Added Services segment, offering innovative solutions such as practice management software, e-services, and financial services to dental and medical practitioners. The market for healthcare IT solutions is projected to reach $400 billion by 2030, presenting a substantial growth opportunity for HSIC. By investing in cutting-edge technologies and expanding its service offerings, Henry Schein can enhance customer loyalty and drive recurring revenue streams.
  • Strategic Acquisitions and Partnerships: Henry Schein can pursue strategic acquisitions and partnerships to expand its product portfolio, geographic reach, and technological capabilities. The company has a history of successful acquisitions, and further strategic deals can enhance its competitive advantage and accelerate growth. For example, acquiring a specialized medical device manufacturer or partnering with a telehealth provider could create synergies and unlock new market opportunities. This ongoing strategy will continue to drive growth.
  • Penetration of Emerging Markets: Henry Schein has the opportunity to expand its presence in emerging markets, where demand for healthcare products and services is growing rapidly. These markets offer significant growth potential due to increasing healthcare spending and expanding access to care. By establishing distribution networks and tailoring its product offerings to local market needs, Henry Schein can capitalize on the growth opportunities in these regions. This initiative has a timeline of 5-10 years.
  • Focus on Digital Dentistry: The increasing adoption of digital dentistry technologies presents a significant growth opportunity for Henry Schein. By offering a comprehensive range of digital dentistry solutions, including CAD/CAM systems, 3D printers, and digital imaging equipment, Henry Schein can help dental practitioners improve efficiency, enhance patient care, and increase profitability. The digital dentistry market is projected to reach $15 billion by 2028, providing a substantial growth opportunity for HSIC.
  • Enhancing Supply Chain Efficiency: Henry Schein can improve its supply chain efficiency through investments in automation, data analytics, and strategic sourcing. By optimizing its supply chain, the company can reduce costs, improve delivery times, and enhance customer satisfaction. This ongoing initiative will involve implementing advanced technologies and streamlining processes to create a more agile and responsive supply chain. The timeline for significant improvements is estimated at 2-3 years.

Fırsatlar

  • Expansion in emerging markets
  • Growth in digital dentistry
  • Strategic acquisitions and partnerships
  • Increased demand for healthcare products and services

Tehditler

  • Economic downturns
  • Increased competition
  • Supply chain disruptions
  • Changes in healthcare regulations

Rekabet Avantajları

  • Established distribution network with a wide reach.
  • Comprehensive product portfolio catering to diverse healthcare needs.
  • Strong relationships with manufacturers and suppliers.
  • Focus on technology and value-added services.
  • Brand reputation and customer loyalty.

HSIC Hakkında

Founded in 1932 and headquartered in Melville, New York, Henry Schein, Inc. has evolved into a global leader in the distribution of healthcare products and services. Initially focused on serving dental practitioners, the company has expanded its reach to include physician practices, government and institutional healthcare clinics, and other alternate care providers. Henry Schein operates through two primary segments: Health Care Distribution, which provides a wide range of dental and medical products, including infection-control supplies, pharmaceuticals, surgical products, and diagnostic tests; and Technology and Value-Added Services, offering practice management software, financial services, e-services, and consulting solutions. The company's comprehensive portfolio supports healthcare professionals in optimizing practice efficiency, enhancing patient care, and navigating the evolving healthcare landscape. With a strong emphasis on innovation and customer service, Henry Schein continues to strengthen its position as a trusted partner for healthcare providers worldwide. The company's global presence enables it to serve a diverse customer base and adapt to regional market dynamics, solidifying its competitive advantage in the healthcare distribution industry. Henry Schein employs approximately 25,000 people.

Ne Yaparlar

  • Distributes dental products and equipment to dental practitioners and laboratories.
  • Provides medical products, including pharmaceuticals and vaccines, to physician practices.
  • Offers practice management software and technology solutions to healthcare providers.
  • Provides value-added services such as financial services and e-services.
  • Offers equipment repair services for dental and medical equipment.
  • Provides consulting and continuing education services for practitioners.
  • Supplies infection-control products and personal protective equipment.

İş Modeli

  • Distributes healthcare products and services to dental and medical professionals.
  • Generates revenue through product sales and service fees.
  • Offers value-added services to enhance customer relationships and drive recurring revenue.
  • Focuses on building strong relationships with manufacturers and suppliers.

Sektör Bağlamı

Henry Schein operates in the medical distribution industry, which is characterized by increasing demand for healthcare products and services, driven by an aging population and expanding access to healthcare. The industry is competitive, with key players focusing on product breadth, distribution efficiency, and value-added services. Henry Schein's strong market position, comprehensive product portfolio, and focus on technology solutions enable it to compete effectively. The global healthcare distribution market is expected to continue growing, presenting significant opportunities for companies like Henry Schein to expand their market share and drive revenue growth. Competitors include companies like ATR, AVTR, BIO, DVA, and GMED.

Kilit Müşteriler

  • Dental practitioners and laboratories
  • Physician practices
  • Government and institutional healthcare clinics
  • Alternate care clinics
AI Güveni: 72% Güncellendi: 8 Şub 2026

Finansallar

Grafik & Bilgi

Henry Schein, Inc. (HSIC) hisse senedi fiyatı: $74.25 (-0.58, -0.78%)

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

HSIC için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

Konsensüs hedefi: $78.14

MoonshotScore

49/100

Bu puan ne anlama geliyor?

MoonshotScore, HSIC'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yatırımcılar Henry Schein, Inc. (HSIC) Hakkında Ne Soruyor

HSIC için değerlendirilmesi gereken temel faktörler nelerdir?

Henry Schein, Inc. (HSIC) şu anda yapay zeka skoru 49/100, düşük puanı gösteriyor. Hisse 22.6x F/K oranıyla işlem görüyor, S&P 500 ortalamasına (~20-25x) yakın. Analist hedefi $78.14 ($74.25'dan +5%). Temel güçlü yan: Global distribution network. İzlenmesi gereken birincil risk: Potential: Economic downturns could reduce demand for healthcare products and services.. Bu bir finansal tavsiye değildir.

HSIC MoonshotScore'u nedir?

HSIC şu anda MoonshotScore'da 49/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

HSIC verileri ne sıklıkla güncellenir?

HSIC fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler HSIC hakkında ne diyor?

Analistler, HSIC için $78.14 konsensüs fiyat hedefi belirledi, bu mevcut fiyattan ($74.25) yukarı yönlü %5 potansiyeli temsil ediyor. Kapsam, al, tut ve sat derecelendirmelerini, kazanç tahminlerini ve son yükseltmeleri veya düşürmeleri içerir. Tüm ayrıntılar için bu sayfadaki Analist Konsensüsü bölümüne bakın.

HSIC'a yatırım yapmanın riskleri nelerdir?

HSIC için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Economic downturns could reduce demand for healthcare products and services.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

HSIC'ın P/E oranı nedir?

Henry Schein, Inc. (HSIC)'nın son P/E oranı 22.6, ki bu da orta bir aralıkta. P/E (fiyat-kazanç) oranı, hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Bağlam için bunu sektördeki emsallerle ve S&P 500 ortalamasıyla (~20-25x) karşılaştırın. Yüksek bir P/E beklenen gelecekteki büyümeyi yansıtabilirken, düşük bir P/E değer düşüklüğünü veya azalan kazançları gösterebilir. Bu bir finansal tavsiye değildir.

HSIC aşırı değerli mi, yoksa düşük değerli mi?

Henry Schein, Inc. (HSIC)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. P/E oranı 22.6. Analist hedefi $78.14 (mevcut fiyattan +5%), analistlerin hisse senedini adil değere yakın gördüğünü gösteriyor. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

HSIC'ın temettü verimi nedir?

Henry Schein, Inc. (HSIC) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Fiyat itibarıyla Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Stock data pending update.
  • Financial metrics based on available data as of 2026-02-08.
Veri Kaynakları

Popüler Hisseler